Data / Drug companies / Unichem Laboratories Limited, India
Unichem Laboratories Limited, India: 63 products in the FDA NDC directory, labeler code 53747
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Unichem Laboratories Limited, India (labeler code 53747) lists 63 products in the FDA National Drug Code Directory, covering 1 finished drug by generic name. By type: 62 bulk ingredients, 1 prescription drugs. Its main marketing category is bulk ingredients. The newest product started marketing on November 13, 2025.
The request: Watch Unichem Laboratories Limited, India (FDA labeler code 53747): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 53747
- Products in commercial distribution
- 63
- Packages
- 65
- Finished drugs by generic name
- 1
- Prescription products
- 1
- Over the counter products
- 0
- Controlled substance products
- Schedule III 1, Schedule IV 2, Schedule V 1
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- November 12, 2001
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 62 | 98.4% |
| Generic drugs (ANDA) | 1 | 1.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 62 | 98.4% |
| Prescription drugs | 1 | 1.6% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Doxazosin mesylate | 1 | 12 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 62 | 98.4% |
| Tablet | 1 | 1.6% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| alpha-Adrenergic Blocker | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Allopurinol | 53747-106 | Powder | Bulk ingredients | November 13, 2025 |
| Zonisamide | 53747-103 | Powder | Bulk ingredients | July 31, 2024 |
| Doxazosin Mesylate | 53747-352 | Tablet | Generic drugs (ANDA) | January 10, 2024 |
| Donepezil hydrochloride | 53747-099 | Powder | Bulk ingredients | January 31, 2023 |
| Solriamfetol hydrochloride | 53747-100 | Powder | Bulk ingredients | March 30, 2022 |
| Topiramate | 53747-097 | Powder | Bulk ingredients | September 28, 2020 |
| Quetiapine fumarate | 53747-101 | Powder | Bulk ingredients | August 26, 2020 |
| Guanfacine hydrochloride | 53747-096 | Powder | Bulk ingredients | March 26, 2020 |
| Solifenacin succinate | 53747-067 | Powder | Bulk ingredients | March 23, 2020 |
| Ticagrelor | 53747-092 | Powder | Bulk ingredients | March 26, 2019 |
| Brexpiprazole | 53747-084 | Powder | Bulk ingredients | January 2, 2019 |
| Montelukast sodium | 53747-079 | Powder | Bulk ingredients | September 28, 2018 |
| Atomoxetine hydrochloride | 53747-059 | Powder | Bulk ingredients | September 28, 2018 |
| Chlorthalidone | 53747-063 | Powder | Bulk ingredients | April 12, 2018 |
| Phenytoin sodium | 53747-082 | Powder | Bulk ingredients | March 29, 2018 |
| Baclofen | 53747-075 | Powder | Bulk ingredients | March 7, 2018 |
| Lacosamide | 53747-069 | Powder | Bulk ingredients | March 7, 2018 |
| Doxazosin mesylate | 53747-076 | Powder | Bulk ingredients | January 17, 2018 |
| Rivaroxaban | 53747-068 | Powder | Bulk ingredients | January 8, 2018 |
| Apremilast | 53747-077 | Powder | Bulk ingredients | December 22, 2017 |
| Vortioxetine hydrobromide | 53747-072 | Powder | Bulk ingredients | March 31, 2017 |
| Labetalol hydrochloride | 53747-037 | Powder | Bulk ingredients | March 29, 2017 |
| Apixaban | 53747-062 | Powder | Bulk ingredients | September 16, 2016 |
| Tofacitinib citrate | 53747-053 | Powder | Bulk ingredients | July 5, 2016 |
| Cinacalcet hydrochloride | 53747-056 | Powder | Bulk ingredients | March 21, 2016 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.